求助PDF
{"title":"R","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0030","DOIUrl":null,"url":null,"abstract":"This chapter presents information on neonatal drugs that begin with R, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Radiological contrast media, Raltegravir, Ranitidine, Recombinant human granulocyte colony-stimulating factors (rhG-CSF), Remifentanil, Rhesus (D) immunoglobulin, Ribavirin = Tribavirin (former BAN), Rifampicin = Rifampin (USAN), Rocuronium, Rotavirus vaccines, and Rubella vaccine","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"33 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"R\",\"authors\":\"Sean Ainsworth\",\"doi\":\"10.1093/med/9780198840787.003.0030\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This chapter presents information on neonatal drugs that begin with R, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Radiological contrast media, Raltegravir, Ranitidine, Recombinant human granulocyte colony-stimulating factors (rhG-CSF), Remifentanil, Rhesus (D) immunoglobulin, Ribavirin = Tribavirin (former BAN), Rifampicin = Rifampin (USAN), Rocuronium, Rotavirus vaccines, and Rubella vaccine\",\"PeriodicalId\":18908,\"journal\":{\"name\":\"Neonatal Formulary\",\"volume\":\"33 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neonatal Formulary\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/med/9780198840787.003.0030\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neonatal Formulary","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/med/9780198840787.003.0030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
引用
批量引用
R
This chapter presents information on neonatal drugs that begin with R, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Radiological contrast media, Raltegravir, Ranitidine, Recombinant human granulocyte colony-stimulating factors (rhG-CSF), Remifentanil, Rhesus (D) immunoglobulin, Ribavirin = Tribavirin (former BAN), Rifampicin = Rifampin (USAN), Rocuronium, Rotavirus vaccines, and Rubella vaccine
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
